SCOT YARNELL: Open Payments
NPI 1457914228 · BUFFALO, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$375 in 19 payments from 10 companies in 2025. Trend: 2023 $1,052 · 2024 $584 · 2025 $375
Food & beverage: $375
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 5 | $95 |
| Teva Pharmaceuticals USA, Inc. | 3 | $62 |
| ABBVIE INC. | 2 | $44 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $42 |
| Janssen Pharmaceuticals, Inc | 2 | $41 |
| Vanda Pharmaceuticals Inc. | 1 | $22 |
| Janssen Scientific Affairs, LLC | 1 | $21 |
| E.R. Squibb & Sons, L.L.C. | 1 | $18 |
| Neurocrine BioSciences, Inc. | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
Products named: ABILIFY MAINTENA, VRAYLAR, REXULTI, CAPLYTA, INVEGA SUSTENNA, UZEDY, FANAPT, AUSTEDO XR.
Industry payments across KS — which companies pay providers there.
